Health Canada authorizes Dexcom G7 15 Day continuous glucose monitoring system for adults
DXCM•Health Canada authorization for Dexcom G7 15 Day
Health Canada has authorized Dexcom's G7 15 Day continuous glucose monitoring system for adults aged 18 and older with diabetes.
The device extends wear time to 15.5 days, aiming to reduce sensor changes and support continuity of monitoring.
The product is not yet available for purchase in Canada.
